Opioid control of MAP kinase cascade

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 487-497

  Schulz, Rüdiger ^a   Eisinger, Daniela A ^a   Wehmeyer, Andrea ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Epidermal growth factor receptor; Extracellular signal regulated kinase; G protein coupled receptor; Human embryonic kidney 293 cell; MAP kinase; Opioid

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; OPIATE; OPIATE RECEPTOR;

CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; EMBRYO; EMBRYO CELL; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; INTERNALIZATION; KIDNEY CELL; NUCLEOTIDE SEQUENCE; PHARMACODYNAMICS; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; REVIEW; SIGNAL TRANSDUCTION;

EID: 4644284602     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.010     Document Type: Article

References (38)

1. M. Asakura, M. Kitakaze, S. Takashima, Y. Liao, F. Ishikura, T. Yoshinaka, H. Ohmoto, K. Node, K. Yoshino, and H. Ishiguro Cardiac hypertrophy is inhibited by antagonism of ADAM 12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy Nat. Med. 8 2003 35 40
2. L. Beguinot, J.A. Hanover, S. Ito, N.D. Richert, M.C. Willingham, and I. Pastan Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors Proc. Natl. Acad. Sci. 82 1985 2774 2778
3. M.M. Belcheva, P.D. Haas, Y. Tan, V.M. Heaton, and C.J. Coscia The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells J. Pharmacol. Exp. Ther. 303 2002 909 918
4. D. Bokemeyer, U. Schmitz, and H.J. Kramer Angiotensin II-induced growth of vascular smooth muscle cells requires an Src-dependent activation of the epidermal growth factor receptor Kidney Int. 58 2000 549 558
5. A.R. Burt, M. Sautel, M.A. Wilson, S. Rees, A. Wise, and G. Milligan Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse delta opioid receptor in rat-1 fibroblasts: effects of receptor expression levels and comparisons with G-protein activation Biochem. J. 320 1996 227 235
6. G. Carpenter, and M.I. Wahl M.B. Sporn A.B. Roberts Peptide Growth Factors and Their Receptors vol. 1 1991 Springer-Verlag New York 69 171
7. G. Carpenter, L. King Jr., and S. Cohen Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor J. Biol. Chem. 254 1979 4884 4891
8. R.E. Carter, and A. Sorkin Endocytosis of functional epidermal growth factor receptor-green fluorescent protein chimera J. Biol. Chem. 273 1998 35000 35007
9. K.A. DeFea, Z.D. Vaughn, E.M. O'Bryan, D. Nishijima, O. Déry, and N.W. Bunnett The proliferative and antiapoptotic effects of substances P are facilitated by formation of a beta-arrestin-dependent scaffolding complex Proc. Natl. Acad. Sci. 97 2000 11086 11091
10. J.L. DeGraff, A.W. Gagnon, J.L. Benovic, and M.J. Orsini Role of arrestins in endocytosis and signaling of alpha2-adrenergic receptor subtypes J. Biol. Chem. 274 1999 11253 11259
11. Z. Gechtman, J.L. Alonso, G. Raab, D.E. Ingber, and M. Klagsbrun The shedding of membrane-anchored heparin-binding epidermal growth factor-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading J. Biol. Chem. 274 1999 28828 28835
12. J.S. Grewal, L.M. Luttrell, and J.R. Raymond G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells J. Biol. Chem. 276 2001 27335 27344
13. A. Gschwind, E. Zwick, N. Prenzel, M. Leserer, and A. Ullrich Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission Oncogene 20 2001 1594 1600
14. B.E. Hawes, T. van Biesen, W.J. Koch, L.M. Luttrell, and R.J. Lefkowitz Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation J. Biol. Chem. 270 1995 17148 17153
15. S. Higashiyama, K. Lau, G.E. Besner, J.A. Abraham, and M. Klagsbrun Structure of heparin-binding EGF-like growth factor. Multiple forms, primary structure, and glycosylation of the mature protein J. Biol. Chem. 267 1992 6205 6212
16. S.M. Johnson, and W.W. Fleming Mechanisms of cellular adaptive sensitivity changes: applications to opioid tolerance and dependence Pharmacol. Rev. 41 1989 435 488
17. H.K. Kramer, M.L. Andria, and E.J. Simon Tyrosine phosphorylation of the deltaopioid receptor: evidence for a role in mitogen-activated protein kinase activation and receptor internalization Biochem. Pharmacol. 60 2000 781 792
18. H.K. Kramer, I. Onoprishvili, M.L. Andria, K. Hanna, K. Sheinkman, L.B. Haddad, and E.J. Simon Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases BMC Pharmacol. 2 2002 5
19. M. Leserer, A. Gschwind, and A. Ullrich Epidermal growth factor receptor signal transactivation Life 49 2000 405 409
20. A. Levitzki, and A. Gazit Tyrosine kinase inhibition: an approach to drug development Science 267 1995 1782 1788
21. L.M. Luttrell Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors Can. J. Physiol. Pharm. 80 2002 375 382
22. L.M. Luttrell G protein-coupled receptor signalling in neuroendocrine systems. "Location, location, location": activation and targeting of MAP kinases by G protein-coupled receptors J. Mol. Endocrinol. 30 2003 117 126
23. M.L. Moss, J.M. White, M.H. Lambert, and R.C. Andrews TACE and other ADAM proteases as targets for drug discovery DDT 6 2001 417 426
24. G. Pearson, F. Robinson, T. Beers Gibson, B.-E. Xu, M. Karandikar, K. Berman, and M.H. Cobb Mitogen-activated protein (MAP) kinase pathways: regulation and physiologic functions Endocr. Rev. 22 2001 153 183
25. K.L. Pierce, A. Tohgo, S. Ahn, M.E. Field, L.M. Luttrell, and F.J. Lefkowitz Epidermal growth factor receptor dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of HB-EGF shedding J. Biol. Chem. 276 2001 23155 23165
26. G.D. Plowman, J.-M. Culouscou, G.S. Whitney, J.M. Green, G.W. Carlton, L. Foy, M.G. Neubauer, and M. Shoyab Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family Proc. Natl. Acad. Sci. 90 1993 1746 1750
27. N. Prenzel, E. Zwick, H. Daub, M. Leserer, R. Abraham, C. Wallasch, and A. Ullrich EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF Nature 402 1999 884 888
28. G. Raab, and M. Klagsbrun Heparin-binding EGF-like growth factor Biochim. Biophys. Acta 1333 1997 F179 F199
29. D.J. Riese II, and D.F. Stern Specificity within the EGF family/ErbB receptor family signaling network BioEssays 20 1998 41 48
30. E.P. Salazar, and E. Rozengurt Bombesin and platelet-derived growth factor induce association of endogenous focal adhesion kinase with Src in intact Swiss 3T3 cells J. Biol. Chem. 274 1999 28371 28378
31. H. Schmidt, S. Schulz, M. Klutzny, T. Koch, M. Handel, and V. Höllt Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells J. Neurochem. 74 2000 414 422
32. R. Schulz, K. Schulz, A. Wehmeyer, and J. Murphy Translocation of phosducin in living neuroblastomaxglioma hybrid cells (NG 108-15) monitored by red-shifted green fluorescent protein Brain Res. 790 1998 347 356
33. R. Schulz, A. Wehmeyer, J. Murphy, and K. Schulz Phosducin, beta-arrestin and opioid receptor migration Eur. J. Pharmacol. 375 1999 349 357
34. R. Schulz, A. Wehmeyer, and K. Schulz Opioid receptor types selectively cointernalize with G protein-coupled receptor kinases 2 and 3 J. Pharmacol. Exp. Ther. 300 2002 376 384
35. B.H. Shah, and K.J. Catt GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences Trends Neurosci. 27 2004 48 53
36. S. Tanimura, K. Nomura, K. Ozaki, M. Tsujimoto, T. Kondo, and M. Kohno Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility J. Biol. Chem. 277 2002 28256 28264
37. T.G. Wolfsberg, P.D. Straight, R.L. Gerena, A.P. Huovila, P. Primakoff, D.G. Myles, and J.M. White ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain Dev. Biol. 169 1995 378 383
38. E. Zwick, P.O. Hackel, N. Prenzel, and A. Ullrich The EGF receptor as central transducer of heterologous signalling systems Trends Pharmacol. Sci. 20 1999 408 412